Reliability and readability of adenoid hypertrophy information generated by five publicly accessible LLM chatbots: A default-setting snapshot study - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Assessment of the Reliability and Readability of Information on Adenoid Hypertrophy from Five Publicly Available LLM Chatbots: A Snapshot Study Using Default Settings

  • By

  • Xiaoming Qian

  • Zhishui Wu

  • Jing Li

  • Qiuyu Su

  • Qian Qin

  • Beibei Zhang

  • July 2, 2026

Share

  • 1

    Adenoid hypertrophy is prevalent in children aged 3 to 8 years, affecting 34%-70% of this population.

  • 2

    Large language models (LLMs) are increasingly used for health information, raising concerns about their reliability.

  • 3

    This study evaluated five LLMs for their ability to provide reliable and readable information on adenoid hypertrophy.

  • 4

    The research utilized the CHART reporting guideline to ensure transparency and reproducibility in the evaluation process.

  • 5

    A total of 63 patient-oriented questions were developed to assess the LLMs' responses regarding adenoid hypertrophy.

Original Source(s)

Reliability and readability of adenoid hypertrophy information generated by five publicly accessible LLM chatbots: A default-setting snapshot study

  • by Xiaoming Qian, Zhishui Wu, Jing Li, Qiuyu Su, Qian Qin, Beibei Zhang

  • July 2, 2026

Related Content

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

Autoinflation May Reduce Repeat Ear Tubes

A small randomized trial suggested lower repeat tympanostomy tube placement rates following tube extrusion among pediatric patients who used home autoinflation therapy.

FDA Okays Weekly Option in Achondroplasia

Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.